Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Samer Al Hadidi

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Al Hadidi, Samer

PropertyValue
keywords Multiple Myeloma
keywords Plasma Cell Myeloma

One or more keywords matched the following items that are connected to Al Hadidi, Samer

Item TypeName
Academic Article How to Treat High-Risk Myeloma at Diagnosis and Relapse.
Academic Article Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study.
Academic Article Treatment Options for Relapsed and Refractory Multiple Myeloma: A Luxury or a Challenge?
Academic Article Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients With Multiple Myeloma.
Academic Article Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture.
Academic Article Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma.
Academic Article Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission.
Academic Article Melflufen in multiple myeloma: the conclusion matters.
Academic Article Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant Neoplasms.
Academic Article Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.
Academic Article Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma-Challenges and Potential Solutions.
Academic Article High dose (conditioning) regimens used prior to autologous stem cell transplantation in multiple myeloma.
Academic Article Thromboprophylaxis in multiple myeloma.
Academic Article Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level.
Academic Article Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives.
Academic Article Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma.
Academic Article Intent Matters: Real-World Applicability of Idecabtagene Vicleucel Usage in the United States.
Academic Article Variability of definition of high-risk multiple myeloma across phase III clinical trials.
Academic Article Is aggressive treatment of smoldering myeloma the path to curing myeloma?
Academic Article Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis.
Academic Article Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis.
Academic Article Racial Differences in Spinal Cord Compression Related Hospitalizations in Patients with Multiple Myeloma.
Academic Article CARTIFAN-1: Concerning fatal adverse events with global use of chimeric antigen receptor-T-cell therapy in multiple myeloma.
Academic Article Overall Survival Analysis of the Use of Elotuzumab in ELOQUENT-3 Trial.
Academic Article Health Disparities Experienced by Hispanic Americans with Multiple Myeloma: A Systematic Review.
Academic Article Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy.
Academic Article Time-to-event surrogate end-points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis.
Academic Article Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience.
Academic Article Gender disparities in multiple myeloma publications.
Academic Article The use of bone-modifying agents in multiple myeloma.
Academic Article Geographic and Racial Disparities in Access to Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials for Multiple Myeloma.
Academic Article Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies.
Academic Article A gene signature can predict risk of MGUS progressing to multiple myeloma.
Academic Article Under-representation of black patients with multiple myeloma in studies supporting International Myeloma Working Group guidelines.
Academic Article Follow up duration of phase III Multiple Myeloma Clinical Trials: A systematic review.
Academic Article Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article.
Academic Article The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.
Academic Article BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions.
Academic Article High NEK2 expression in myeloid progenitors suppresses T?cell immunity in multiple myeloma.
Academic Article Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma.
Academic Article Perspectives on the Treatment of Multiple Myeloma.
Academic Article Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up.
Academic Article Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.
Academic Article Targeting GPRC5D in multiple myeloma.

Search Criteria
  • Multiple Myeloma